Omega-3 phospholipid

N/A

Report date: 2025/01/09 20:00:05
NME

Base Information

Drug NameOmega-3 phospholipid
Drug Alias NameCaPreNKPL-66
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLipid modulators
TargetsLipid
Therapy Area/IndicationsHypertriglyceridemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesMexico
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGrace Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGrace Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsHypertriglyceridemia

Other Information

ATC CodeN/A
Related LinksN/A